Host: Larry Kaskel, MD

Guest: Roxanna Mehran, MD

In long term data presented from the RAVEL trial, the original trial reporting a remarkable decrease in the rate of restenosis with DES, the long-term incidence of death or heart attack was not significantly different between DES and bare metal stents.